Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > News > Altair Nanotechnologies Licenses RenaZorb(TM)

January 31st, 2005

Altair Nanotechnologies Licenses RenaZorb(TM)

Abstract:
Altair Nanotechnologies announced today that a licensing agreement has been signed with California-based Spectrum Pharmaceuticals, giving Spectrum the exclusive worldwide rights for human therapeutic and diagnostic applications to develop, market and sell its RenaZorb™ product line. Altair's RenaZorb™ products, which target an emerging billion-dollar-plus market, are for phosphate control in patients with Chronic Kidney Disease (CKD) and hyperphosphatemia, high phosphate levels in blood, associated with End Stage Renal Disease (ESRD). These products are non-aluminum-, non-calcium-based phosphate binders, which utilize Altair's proprietary lanthanum nanomaterial technology.

Source:
marketwire

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related Links

Spectrum Pharmaceuticals

Related News Press

Nanomedicine

The virus trap: Hollow nano-objects made of DNA could trap viruses and render them harmless July 16th, 2021

NYUAD study maps nanobody structure, leading to new ways to potentially fight diseases July 4th, 2021

Optical tweezer technology tweaked to overcome dangers of heat June 25th, 2021

Arrowhead Presents Preclinical Data on ARO-DUX4 at FSHD Society International Research Congress June 25th, 2021

Announcements

Daikin Industries becomes OCSiAl shareholder July 27th, 2021

The National Space Society Congratulates Blue Origin and Jeff Bezos for the Spectacular First Crewed Flight of the New Shepard: Well-Tested Suborbital Tourist Rocket Soars to 63 Miles; Opens New Frontiers July 21st, 2021

Scientists take first snapshots of ultrafast switching in a quantum electronic device: They discover a short-lived state that could lead to faster and more energy-efficient computing devices July 16th, 2021

Researchers discover a new inorganic material with lowest thermal conductivity ever reported July 16th, 2021

Patents/IP/Tech Transfer/Licensing

Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020

HORIBA Medical and CEA-Leti Strengthen Their Partnership to Develop Tomorrow’s Diagnostics at the Point of Care July 21st, 2020

A new study published on the cover of Science could bolster the development of batteries, fuel cells, 3D printing technologies and more May 1st, 2020

New green technology from UMass Amherst generates electricity 'out of thin air' Renewable device could help mitigate climate change, power medical devices February 17th, 2020

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project